Non-Hodgkin lymphomas in childhood: How to move on?

Non-Hodgkin lymphomas of childhood represent a diverse group of neoplasms with different clinical, pathological, immunophenotypical and genetic features. A vast majority of childhood non-Hodgkin lymphomas could be classified into one of the three major histological subgroups: mature B-cell...

Full description

Bibliographic Details
Main Authors: Dokmanović Lidija, Rodić Predrag, Krstovski Nada, Lazić Jelena, Janić Dragana
Format: Article
Language:English
Published: Serbian Medical Society 2014-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0370-8179/2014/0370-81791408498D.pdf
id doaj-c20f802e289d4562b900d069c3b2ce50
record_format Article
spelling doaj-c20f802e289d4562b900d069c3b2ce502021-01-02T15:50:39ZengSerbian Medical SocietySrpski Arhiv za Celokupno Lekarstvo0370-81792014-01-011427-849850410.2298/SARH1408498D0370-81791408498DNon-Hodgkin lymphomas in childhood: How to move on?Dokmanović Lidija0Rodić Predrag1Krstovski Nada2Lazić Jelena3Janić Dragana4Faculty of Medicine, Belgrade + University Children’s Hospital, Department of Hematology and Oncology, BelgradeUniversity Children’s Hospital, Department of Hematology and Oncology, BelgradeFaculty of Medicine, Belgrade + University Children’s Hospital, Department of Hematology and Oncology, BelgradeFaculty of Medicine, Belgrade + University Children’s Hospital, Department of Hematology and Oncology, BelgradeFaculty of Medicine, Belgrade + University Children’s Hospital, Department of Hematology and Oncology, BelgradeNon-Hodgkin lymphomas of childhood represent a diverse group of neoplasms with different clinical, pathological, immunophenotypical and genetic features. A vast majority of childhood non-Hodgkin lymphomas could be classified into one of the three major histological subgroups: mature B-cell neoplasms, lymphoblastic lymphomas or anaplastic large cell lymphomas. Modern therapeutic strategies lead to cure in more than 80% of patients. Conversely, refractory diseases, as well as disease relapse convey a dismal prognosis. This fact requires much better stratification based on prognostic markers which would ideally recognize distinct groups of patients requiring different therapeutic regimens. Defining novel diagnostic and prognostic markers should improve diagnosis and prognosis as well as patient follow-up. It should also allow introduction of individually tailored treatment regimens in selected groups of patients with non-Hodgkin lymphomas, with the main goal of improving treatment results and decreasing short- and long-term complications. [Projekat Ministarstva nauke Republike Srbije, br. 41004]http://www.doiserbia.nb.rs/img/doi/0370-8179/2014/0370-81791408498D.pdfnon-Hodgkin lymphomachildrenclassificationdiagnosisprognosistreatment
collection DOAJ
language English
format Article
sources DOAJ
author Dokmanović Lidija
Rodić Predrag
Krstovski Nada
Lazić Jelena
Janić Dragana
spellingShingle Dokmanović Lidija
Rodić Predrag
Krstovski Nada
Lazić Jelena
Janić Dragana
Non-Hodgkin lymphomas in childhood: How to move on?
Srpski Arhiv za Celokupno Lekarstvo
non-Hodgkin lymphoma
children
classification
diagnosis
prognosis
treatment
author_facet Dokmanović Lidija
Rodić Predrag
Krstovski Nada
Lazić Jelena
Janić Dragana
author_sort Dokmanović Lidija
title Non-Hodgkin lymphomas in childhood: How to move on?
title_short Non-Hodgkin lymphomas in childhood: How to move on?
title_full Non-Hodgkin lymphomas in childhood: How to move on?
title_fullStr Non-Hodgkin lymphomas in childhood: How to move on?
title_full_unstemmed Non-Hodgkin lymphomas in childhood: How to move on?
title_sort non-hodgkin lymphomas in childhood: how to move on?
publisher Serbian Medical Society
series Srpski Arhiv za Celokupno Lekarstvo
issn 0370-8179
publishDate 2014-01-01
description Non-Hodgkin lymphomas of childhood represent a diverse group of neoplasms with different clinical, pathological, immunophenotypical and genetic features. A vast majority of childhood non-Hodgkin lymphomas could be classified into one of the three major histological subgroups: mature B-cell neoplasms, lymphoblastic lymphomas or anaplastic large cell lymphomas. Modern therapeutic strategies lead to cure in more than 80% of patients. Conversely, refractory diseases, as well as disease relapse convey a dismal prognosis. This fact requires much better stratification based on prognostic markers which would ideally recognize distinct groups of patients requiring different therapeutic regimens. Defining novel diagnostic and prognostic markers should improve diagnosis and prognosis as well as patient follow-up. It should also allow introduction of individually tailored treatment regimens in selected groups of patients with non-Hodgkin lymphomas, with the main goal of improving treatment results and decreasing short- and long-term complications. [Projekat Ministarstva nauke Republike Srbije, br. 41004]
topic non-Hodgkin lymphoma
children
classification
diagnosis
prognosis
treatment
url http://www.doiserbia.nb.rs/img/doi/0370-8179/2014/0370-81791408498D.pdf
work_keys_str_mv AT dokmanoviclidija nonhodgkinlymphomasinchildhoodhowtomoveon
AT rodicpredrag nonhodgkinlymphomasinchildhoodhowtomoveon
AT krstovskinada nonhodgkinlymphomasinchildhoodhowtomoveon
AT lazicjelena nonhodgkinlymphomasinchildhoodhowtomoveon
AT janicdragana nonhodgkinlymphomasinchildhoodhowtomoveon
_version_ 1724352420138450944